Sentinel Study Transparency: FDA Tells Sponsors To Watch Journals, Conferences, Its Website For Results
Executive Summary
MaPP indicates limited circumstances when Office of Surveillance and Epidemiology will tell a sponsor about the release of Sentinel safety study results.